Kevin Georgek is a partner in the Intellectual Property practice group and is based in the Firm's New York office. His practice is focused on life-sciences patent litigation, including matters arising under the Biologics Price Competition and Innovation Act and the Hatch-Waxman Act. Kevin also represents multinational pharmaceutical and biotechnology companies in post-grant proceedings before the U.S. Patent and Trademark Office and he provides strategic patent counseling to companies in the life-sciences industry.

Prior to practicing law, Kevin was as an operations analyst at a large biopharmaceutical company.